Most people think of Medicare drug coverage as Part D, the prescriptions you pick up at the pharmacy. But a whole category of medications never touches a pharmacy counter. These are the drugs a doctor or nurse administers to you in a clinical setting: infusions, in-office injections, and intravenous chemotherapy. Medicare covers these under Part B, the medical side, not Part D, and the way they are billed and what you pay work very differently. Understanding this split matters, because the medications involved are often expensive and the cost structure is not what most people expect.
The buy-and-bill world trips people up constantly, because they assume all their drug costs run through Part D and the $2,000 cap. They do not. An expensive infusion is a Part B drug, and on Original Medicare alone that 20 percent has no ceiling. This is one of the clearest arguments for a strong Medigap plan, or for understanding your Advantage plan's out-of-pocket maximum. If you are starting any kind of infusion or in-office injection therapy, let us make sure your coverage protects you before the bills start.
What counts as a Part B drug
Part B generally covers drugs that are administered by a healthcare provider in a clinical setting rather than something you take yourself at home. That includes drugs given by infusion in an outpatient clinic, injections you receive in the doctor's office, intravenous chemotherapy, and certain other provider-administered medications. The common thread is that a professional has to give you the drug, so it is billed as part of the medical service rather than as a prescription you fill. If you can pick it up at the pharmacy and take it yourself, it almost always falls under Part D instead.
The buy-and-bill model
Part B drugs typically run through what is called the buy-and-bill model. The provider purchases the drug, keeps it on hand, administers it to you, and then bills Medicare for both the drug and the service of giving it to you. You do not buy the drug at a pharmacy and bring it in. This is why an infusion or an in-office injection shows up on your Medicare medical claims rather than your drug plan. The provider is the one who acquired the medication and delivered it, and the billing reflects that.
What you pay: the 20 percent coinsurance
Under Original Medicare, after you meet the annual Part B deductible, you generally pay 20 percent coinsurance for Part B drugs. For an inexpensive injection that is a small amount, but for an expensive infused biologic or chemotherapy drug, 20 percent of a very large number can be a serious sum. The important thing to understand is that Original Medicare on its own has no annual out-of-pocket cap on that 20 percent, so without additional coverage your exposure on a costly Part B drug is effectively open-ended.
Why Medigap or an Advantage cap matters here
This is where your supplemental coverage does real work. If you have Original Medicare with a comprehensive Medigap plan like Plan G, the Medigap plan generally picks up the 20 percent Part B coinsurance, which can bring your cost for an expensive infused drug down close to zero after the Part B deductible. If you are in a Medicare Advantage plan instead, your Part B drug cost-sharing runs through the plan and counts toward its annual out-of-pocket maximum, which caps your total exposure for the year. Either way, the protection against that uncapped 20 percent is one of the most valuable things your coverage provides for provider-administered drugs.
Starting an infusion or in-office drug therapy?
Provider-administered drugs run under Part B with 20 percent coinsurance and no cap on Original Medicare alone. Let me make sure your Medigap or Advantage coverage actually shields you from that exposure.
Book a Free CallPart B drugs vs Part D drugs at a glance
| Feature | Part B drugs | Part D drugs |
|---|---|---|
| How you get it | Administered by a provider in a clinical setting | Self-administered, filled at a pharmacy |
| Typical examples | Infusions, in-office injections, IV chemotherapy | Pills, most inhalers, self-injected pens |
| How it is billed | Buy and bill: provider buys the drug and bills Medicare | Your Part D plan pays the pharmacy |
| Your cost-sharing | Generally 20 percent Part B coinsurance | Formulary tier copay or coinsurance |
| What limits your exposure | Medigap or an Advantage out-of-pocket maximum | The $2,000 annual Part D out-of-pocket cap (since 2025) |
Why the distinction is worth getting right
Because Part B and Part D drugs are billed and capped differently, the same condition can produce very different out-of-pocket costs depending on which pathway your treatment falls under. If you are facing a course of infused or injected medication, it pays to know it is a Part B drug and to make sure your supplemental coverage actually shields you from that 20 percent. Your exact costs depend on your specific drug, your provider, and the coverage you carry, so the most reliable way to know what you will pay is to look at your particular situation.